These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE. Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604 [Abstract] [Full Text] [Related]
5. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P. Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212 [Abstract] [Full Text] [Related]
6. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ. Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856 [Abstract] [Full Text] [Related]
7. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors. Dettori S, Candido A, Kondili LA, Chionne P, Taffon S, Genovese D, Iudicone P, Miceli M, Rapicetta M. J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663 [Abstract] [Full Text] [Related]
8. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos NC, Mimidis K, Karafoulidou A, Hatzakis A. Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585 [Abstract] [Full Text] [Related]
9. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S. Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315 [Abstract] [Full Text] [Related]
10. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H, Japanese Red Cross NAT Screening Research Group. Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150 [Abstract] [Full Text] [Related]
12. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A. Trop Gastroenterol; 2007 Jul; 28(1):19-23. PubMed ID: 17896605 [Abstract] [Full Text] [Related]
14. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
15. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors]. Cavdar E, Kuştimur S, Doğruman Al F. Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694 [Abstract] [Full Text] [Related]